Hydroxypropyl betadex (ZyVersa Therapeutics)

羟丙基倍他环糊精 (ZyVersa Therapeutics)

Report date: 2025/12/01 16:08:53

Base Information

Drug NameHydroxypropyl betadex (ZyVersa Therapeutics)

Drug Alias NameCholesterol efflux mediator VAR-200 (ZyVersa)VAR-200 (ZyVersa)hydroxypropylbetacyclodextrin (Variant Pharmaceuticals)hydroxypropylbetacyclodextrin (ZyVersa Therapeutics)2-hydroxypropyl-β-cyclodextrin (ZyVersa Therapeutics) +[16]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLipid metabolism modulatorsLipid uptake modulatorsATP binding cassette subfamily A member 1 stimulants +[4]

TargetsATP binding cassette subfamily A member 1Subfamily G ATP binding cassette transporter

Therapy Area/IndicationsDiabetes Mellitus, Type 2ProteinuriaDiabetic Nephropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesL&F Research LLC

China Registration ClassN/A

Develop Information

Active CompaniesZyVersa Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2Proteinuria

Inactive IndicationsDiabetic Nephropathies

Other Information

ATC CodeN/A